首页> 外文期刊>Journal of Pregnancy >Adverse Effects of Carbetocin versus Oxytocin in the Prevention of Postpartum Haemorrhage after Caesarean Section: A Randomized Controlled Trial
【24h】

Adverse Effects of Carbetocin versus Oxytocin in the Prevention of Postpartum Haemorrhage after Caesarean Section: A Randomized Controlled Trial

机译:卡贝霉素与催产素在预防剖宫产后产后出血中的不良反应:一项随机对照试验

获取原文
           

摘要

Purpose. To compare the incidence of nausea, vomiting, and arterial hypotension between carbetocin and oxytocin to prevent haemorrhage after caesarean section (CS). Methods. A randomized controlled trial in term pregnant women undergoing planned CS. Groups were randomized to carbetocin or oxytocin. Blood pressure (BP), heart rate, presence of nausea/vomitus, and need for vasopressors were evaluated throughout surgery. Preoperative and postoperative haemoglobin and haematocrit levels were compared. Results. Fifty-eight women were randomized (carbetocin ; oxytocin ). Both medications had hypotensive effect, difference in BP for carbetocin versus oxytocin systolic (14.4 ± 2.4?mmHg versus 8.5 ± 1.8?mmHg); diastolic (7.8 ± 1.6?mmHg versus 8.9 ± 3.0?mmHg) without significant difference between the drugs ( and ). Both groups had similar needs for vasopressors. The presence of nausea was not rare, but the difference was not statistically significant (). Average blood loss was slightly lower in the carbetocin group but not statistically significant (). Conclusion. In planned CS, a possible clinical significant lower incidence of nausea after carbetocin was noted but this was not statistically significant. There were no differences regarding BP, heart rate, the need for vasopressor, and blood loss. The study was registered in the International Journal of Clinical Trials (ISRCTN 95504420, 2/2017).
机译:目的。比较卡贝托星和催产素之间恶心,呕吐和动脉低血压的发生率,以防止剖腹产(CS)后大出血。方法。一项接受计划CS的足月孕妇的随机对照试验。将各组随机分为卡比托星或催产素。在整个手术过程中评估血压(BP),心率,恶心/呕吐的存在以及是否需要升压药。比较术前和术后血红蛋白和血细胞比容水平。结果。 58名妇女被随机分配(卡贝托星;催产素)。两种药物均具有降压作用,卡贝托星与催产素收缩压的血压差异(14.4±2.4?mmHg与8.5±1.8?mmHg);舒张压(7.8±1.6?mmHg与8.9±3.0?mmHg)在两种药物之间(和)没有显着差异。两组对升压药的需求相似。恶心的存在并不罕见,但差异无统计学意义()。 Carbetocin组的平均失血量略低,但无统计学意义()。结论。在计划中的CS中,发现卡贝托星后恶心的临床发生率可能较低,但这在统计学上并不显着。血压,心率,是否需要使用升压药和失血没有差异。该研究已在《国际临床试验杂志》(ISRCTN 95504420,2/2017)中进行了注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号